The Motley Fool··Leo SunJohnson & Johnson Sheds 'Boring' Tag as Dividend King Pivots Toward Growth
J&J transforms from income stock into growth engine with 50% rally in 12 months, backed by innovative medicines and medical device expansion despite 2026 patent cliff.
JNJEPS growthdrug launches